$2.48T
Total marketcap
$66.33B
Total volume
BTC 50.30%     ETH 16.00%
Dominance

Satellos Bioscience Inc. 0ITA.F Stock

0.3 EUR {{ price }} 4.895104% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
39.18M EUR
LOW - HIGH [24H]
0.3 - 0.3 EUR
VOLUME [24H]
350 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.12 EUR

Satellos Bioscience Inc. Price Chart

Satellos Bioscience Inc. 0ITA.F Financial and Trading Overview

Satellos Bioscience Inc. stock price 0.3 EUR
Previous Close 0.33 EUR
Open 0.32 EUR
Bid 0.32 EUR x N/A
Ask 0.39 EUR x N/A
Day's Range 0.32 - 0.32 EUR
52 Week Range 0.11 - 0.52 EUR
Volume 120 EUR
Avg. Volume 2 EUR
Market Cap 37M EUR
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.12 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0ITA.F Valuation Measures

Enterprise Value 35.81M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 6.3599997
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -4.661

Trading Information

Satellos Bioscience Inc. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 29.30%
S&P500 52-Week Change 20.43%
52 Week High 0.52 EUR
52 Week Low 0.11 EUR
50-Day Moving Average 0.36 EUR
200-Day Moving Average 0.23 EUR

0ITA.F Share Statistics

Avg. Volume (3 month) 2 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 112.77M
Float 95.06M
Short Ratio N/A
% Held by Insiders 9.38%
% Held by Institutions 14.18%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -56.71%
Return on Equity (ttm) -198.49%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -67634 EUR
EBITDA -7682832 EUR
Net Income Avi to Common (ttm) -10872292 EUR
Diluted EPS (ttm) -0.2
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.98M EUR
Total Cash Per Share (mrq) 0.03 EUR
Total Debt (mrq) 2.03M EUR
Total Debt/Equity (mrq) 95.24 EUR
Current Ratio (mrq) 1.002
Book Value Per Share (mrq) 0.05

Cash Flow Statement

Operating Cash Flow (ttm) -4803066 EUR
Levered Free Cash Flow (ttm) -1736625 EUR

Profile of Satellos Bioscience Inc.

Country Germany
State ON
City Toronto
Address 79 Wellington Street West
ZIP M5K 1N2
Phone 647-660-1780
Website https://satellos.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of duchenne. The company's MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Q&A For Satellos Bioscience Inc. Stock

What is a current 0ITA.F stock price?

Satellos Bioscience Inc. 0ITA.F stock price today per share is 0.3 EUR.

How to purchase Satellos Bioscience Inc. stock?

You can buy 0ITA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Satellos Bioscience Inc.?

The stock symbol or ticker of Satellos Bioscience Inc. is 0ITA.F.

Which industry does the Satellos Bioscience Inc. company belong to?

The Satellos Bioscience Inc. industry is Biotechnology.

How many shares does Satellos Bioscience Inc. have in circulation?

The max supply of Satellos Bioscience Inc. shares is 130.6M.

What is Satellos Bioscience Inc. Price to Earnings Ratio (PE Ratio)?

Satellos Bioscience Inc. PE Ratio is now.

What was Satellos Bioscience Inc. earnings per share over the trailing 12 months (TTM)?

Satellos Bioscience Inc. EPS is -0.12 EUR over the trailing 12 months.

Which sector does the Satellos Bioscience Inc. company belong to?

The Satellos Bioscience Inc. sector is Healthcare.